CHE · XBRL financial data

Chemed financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CHE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	2,080	2,139	2,135	2,264	2,431	2,530
Revenue from contracts with customers	1,335	1,261	1,202	1,315	1,531	—
Cost of goods and services sold	1,378	1,369	1,370	1,466	1,577	1,707
Selling, general and administrative	330	367	359	395	424	417
Total operating expenses	—	—	1,791	1,924	2,065	2,192
Other operating income (expense)	75	(1)	(4)	(2)	(0)	(3)
Operating income (loss)	390	343	343	341	366	338
Interest expense	2	2	5	3	2	2
Other income (expense)	(0)	0	0	0	0	(0)
Income tax expense (benefit)	77	82	80	78	97	91
Net income (loss)	319	269	250	273	302	265
Earnings per share, basic USD per share	20.02	17.14	16.72	18.11	20.10	18.42
Earnings per share, diluted USD per share	19.48	16.85	16.53	17.93	19.89	18.34
Weighted average shares, basic millions of shares	16	16	15	15	15	14
Weighted average shares, diluted millions of shares	16	16	15	15	15	14

Fiscal years (CHE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	163	33	74	264	178	75
Accounts receivable	127	137	139	182	171	183
Inventory	7	10	10	12	8	8
Total current assets	329	230	273	501	395	303
Property and equipment, net	188	194	200	204	201	206
Right-of-use asset	123	125	136	126	127	131
Goodwill	579	579	581	585	667	667
Total assets	1,435	1,343	1,442	1,668	1,669	1,538
Accounts payable	54	73	42	64	44	64
Current portion of long-term debt	—	—	5	—	—	—
Total current liabilities	299	302	297	312	286	287
Long-term debt	—	185	93	—	—	—
Lease liability, non-current	99	101	111	101	99	103
Total liabilities	534	719	643	560	550	559
Retained earnings	1,724	1,970	2,198	2,447	2,722	2,955
Total stockholders' equity	901	623	799	1,108	1,119	979
Total liabilities and equity	1,435	1,343	1,442	1,668	1,669	1,538
Common shares outstanding (cover page) millions of shares	16	15	15	15	15	14

Fiscal years (CHE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	319	269	250	273	302	265
Depreciation and amortization	57	59	59	61	63	65
Net cash from operating activities	489	309	310	330	417	388
Purchases of property and equipment	59	59	57	57	50	63
Net cash from investing activities	(62)	(58)	(59)	(61)	(144)	(59)
Share repurchases	176	576	115	68	361	432
Dividends paid	21	22	22	24	27	32
Net cash from financing activities	(271)	(381)	(209)	(80)	(359)	(433)

SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Chemed	48	691	57*	13.0M	Q3 FY26 10-QSep 30, 2026
Option Care Health	299	1,494	115*	149.8M	Q3 FY26 10-QSep 30, 2026
BrightSpring Health Services	718	4,213	204*	199.0M	Q3 FY26 10-QSep 30, 2026
Addus HomeCare	100	377	40*	18.7M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.